Abstract
Objective The aim of the study was to investigate the prevalence of cardiometabolic risk factors (CMRFs), target organ damage and its associated factors among adults in Freetown, Sierra Leone.
Design This community-based cross-sectional study used a stratified multistage random sampling method to recruit adult participants.
Setting The health screening study was conducted between October 2019 and October 2021 in Western Area Urban, Freetown, Sierra Leone.
Participants A total of 2394 adults Sierra Leoneans aged 20 years, or more were enrolled.
Outcome measure Anthropometric data, fasting lipid profiles, fasting plasma glucose, target organ damage, clinical profiles and demographic characteristic of participants were described. The cardiometabolic risks were further related to target organ damage.
Results The prevalence of known CMRFs was 35.3% for hypertension, 8.3% for diabetes mellitus, 21.1% for dyslipidemia, 10.0% for obesity, 13.4% for smoking and 37.9% for alcohol. Additionally, 16.1% had left ventricular hypertrophy (LVH) by electrocardiogram (ECG), 14.2% had LVH by 2D-Echo, and 11.4% had chronic kidney disease. The odds of developing ECG-LVH were higher with diabetes [OR = 1.255, 95% C.I. (0.822 - 1.916) and dyslipidaemia [OR = 1.449, 95% C.I. (0.834 - 2.518). The association factors for higher odds of LVMI by echo were dyslipidemia [OR = 1.844, 95% C.I (1.006-3.380)] and diabetes mellitus [OR =1.176, 95% C.I. (0.759-1.823)]. The odds of having CKD were associated with diabetes mellitus [OR =1.212, 95% CI (0.741-1.983)] and hypertension [OR =1.163, 95% CI (0.887-1.525)]. A low optimal cut-off point for ECG-LVH (male 24.5mm vs female 27.5mm) as a target organ damage was required to maximize sensitivity and specificity by a receiver operating characteristic (ROC) curve since the odds for LVH by ECG was low.
Conclusions This study provides novel data-driven information on the burden of cardiometabolic risks and its association with preclinical target organ damage in a resource limited setting. It illustrates the need for interventions in improve cardiometabolic health screening and management among adults in Sierra Leoneans.
Strengths
A major strength of this study is its community-based design and the first study of its kind on a larger population in Sierra Leone.
The study was statistically powered to produce results that are representative of adults in Sierra Leone.
Limitations
The study is limited as it could not conclude direct causality inference of risk factors and effect outcomes.
Since some of the outcomes (fasting plasma glucose, HbA1c and fasting lipid profile) are limited by the reliance on single time point measurements, it may result in measurement errors and the potential of underestimating cardiometabolic risk factors.
Chronic kidney disease (CKD) assessment by single serum creatinine without assessing for proteinuria, which also indicates the presence of CKD, will lead to underestimation of CKD.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
identification number researchregistry 8201
Funding Statement
This study was funded by Ecobank Sierra Leone Limited
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research proposal, questionnaire and consent form were approved by the Sierra Leone Ethics and Scientific Review Committee. The institution does not provide ethics reference identification number. Anonymity was maintained using serial coded numbers assigned to the case records and the extracted data was handled with strict confidentiality. The protocol of this study also registered under Research Registry with the unique identification number researchregistry8201, which is available at https://www.researchregistry.com/browse-the-registry#home/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
trkoroma90{at}gmail.com
sanniesay{at}gmail.com
ssallieu{at}yahoo.com
lakoh2009{at}gmail.com
abockarie{at}ucc.edu.gh
berylonome{at}gmail.com
samjokanu{at}yahoo.com
joshuacoker001{at}yahoo.com
abdulpjalloh{at}yahoo.co.uk
vicyandi{at}gmail.com
bigbrosocont{at}gmail.com
mohamed85smith{at}gmail.com
zenu2{at}btinternet.com
durodamil{at}yahoo.co.uk
Conflict of interest: Authors declare no conflict of interest.
Funding Ecobank Limited Sierra Leone
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- BMI
- Body Mass Index
- CMD
- Cardiometabolic Disease
- CMRF
- Cardiometabolic risk factors
- CVD
- cardiovascular disease
- CVDRF
- cardiovascular disease risk factors
- DBP
- diastolic blood pressure
- LDL-C
- Low density lipoprotein cholesterol
- MIC
- low-and middle-income countries
- LVH
- left ventricular hypertrophy
- LVMI
- Left ventricular mass index
- NCD
- Non-communicable disease
- HDL-C
- High density lipoprotein cholesterol
- SBP
- systolic blood pressure
- SLE
- Leones currency
- TG
- triglyceride
- TOD
- target organ damage
- WC
- waist circumference
- WHO
- World Health Organization